Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-333943
Filing Date
2021-11-18
Accepted
2021-11-18 16:57:54
Documents
1
Period of Report
2021-11-18

Document Format Files

Seq Description Document Type Size
1 6-K d605993d6k.htm 6-K 14476
  Complete submission text file 0001193125-21-333943.txt   15449
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 211425112
SIC: 2834 Pharmaceutical Preparations